SULANTRIX LTD
Significant control: David Hugh Williams (25–50%), Patrick Alexander Eyers (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Sulantrix Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
SULANTRIX LTD is an active private limited company (company number 13843002) incorporated on 12 January 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£160k and cash of £70k, with 3 employees on average. Net assets fell 69% on the prior period (−£95k).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Dr David Hugh Williams
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Patrick Alexander Eyers
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 January 20224 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 26 January 2027in 95 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£160k | £70k | £44k | £36k | — | — | 3 |
| 31 March 2024 | −£95k | £140k | £11k | £16k | — | — | 4 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-160,434 at 31 March 2025
- Net assets down 25% or more on the prior period-68.9% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.16
- Cash at bank of £50,000 or moreCash £70,435
- Incorporated two to five years agoIncorporated 12 January 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 95 days
- Next accounts duein 69 days
- Accounts period endNet liabilities £160k · small accounts
- Accounts period endNet liabilities £95k · small accounts
- Incorporated
Similar companies in London
- CV IMAGING AND RESEARCH UK LTDLondon · inc. Jan 2022
- BEYOND BLOOD DIAGNOSTICS LTDLondon · inc. Jan 2022
- TIGERMED UK LTDLondon · inc. Jan 2022
- CDT EQUITY LTDLondon · inc. Feb 2022
- NOMORA LIMITEDLondon · inc. Dec 2021
- QUANTICO MRI LIMITEDLondon · inc. Feb 2022
All companies incorporated on 12 January 2022 · in Jan 2022.
Reminders for SULANTRIX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.